[1] |
Fuentes I Ferrer MV, Sáez-Durán S, Bueno-Marí R, et al. Health implications of the finding of Angiostrongylus cantonensis,the main cause of eosinophilic meningoencephalitis, in continental Europe (Valencia,Spain)[J]. Rev Esp Salud Publica, 2023, 97:1-6.
|
[2] |
陈家旭, 蔡玉春, 艾琳, 等. 我国重要人体寄生虫病防控现状与挑战[J]. 检验医学, 2021, 36(10):993-1000.
doi: 10.3969/j.issn.1673-8640.2021.010.001
|
[3] |
Cui Y, Shen M, Meng SJ. Lung CT findings of angiostrongyliasis cantonensis caused by Angiostrongylus cantonensis[J]. Clin Imaging, 2011, 35(3):180-183.
|
[4] |
潘火云, 谭丽梅, 徐翼, 等. 12例儿童广州管圆线虫病临床分析[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(5):668-672.
doi: 10.12140/j.issn.1000-7423.2022.05.016
|
[5] |
中华人民共和国卫生部. 广州管圆线虫病诊断标准:WS/T 321—2010[S]. 北京: 中国标准出版社, 2010.
|
[6] |
阴赪宏, 甘绍伯, 刘建, 等. 广州管圆线虫病临床诊疗方案(试行)[J]. 临床和实验医学杂志, 2006, 5(10):1473-1474.
|
[7] |
中国疾病预防控制中心寄生虫病预防控制所. 2015年全国人体重点寄生虫病现状调查报告[M]. 北京: 人民卫生出版社, 2018.
|
[8] |
张泽娜, 叶燕芬, 唐屹君, 等. 2017—2019年深圳市寄生虫疑似病例血清学分析[J]. 新发传染病电子杂志, 2021, 6(2):125-128.
doi: 10.19871/j.cnki.xfcrbzz.2021.02.011
|
[9] |
Xie M, Zhou Z, Guo SH, et al. Next-generation sequencing specifies Angiostrongylus eosinophilic meningoencephalitis in infants: Two case reports[J]. Medicine (Baltimore), 2019, 98(35):e16985.
|
[10] |
黄春燕, 刘榆华, 谢汉国, 等. 《广州管圆线虫病诊断标准》(WS/T 321—2010)在福建省和云南省实施情况的跟踪评价[J]. 热带病与寄生虫学, 2024, 22(2):112-116.
|
[11] |
Amornpojnimman T, Sanghan N, Ekpitakdamrong N, et al. Angiostrongylosis meningomyelitis without blood eosinophilia[J]. J Infect Dev Ctries, 2021, 15(12):1933-1936.
|
[12] |
Jhan KY, Lai GJ, Chang PK, et al. Angiostrongylus cantonensis causes cognitive impairments in heavily infected BALB/c and C57BL/6 mice[J]. Parasit Vectors, 2020, 13(1):405.
|
[13] |
许靖云, 周宇晨, 黄硕, 等. 广州管圆线虫免疫调控机制及诊断技术研究进展[J]. 热带生物学报, 2023, 14(1):60-70.
|
[14] |
周昀, 杨根东. 广州管圆线虫病颅脑及胸部感染一例[J]. 罕少疾病杂志, 2022, 29(1):13-14,29.
|
[15] |
Jacob J, Siraj MA, Steel A, et al. Evaluation of the mechanism of action of albendazole on adult rat lungworm (Angiostrongylus cantonensis)[J]. Exp Parasitol, 2022, 242:108355.
|
[16] |
耿艺介, 黄达娜, 高世同, 等. 阿苯达唑治疗广州管圆线虫感染的免疫学效应研究[J]. 寄生虫与医学昆虫学报, 2011, 18(2):70-75.
|
[17] |
Jitpimolmard S, Sawanyawisuth K, Morakote N, et al. Albendazole therapy for eosinophilic meningitis caused by Angiostrongylus cantonensis[J]. Parasitol Res, 2007, 100(6):1293-1296.
doi: 10.1007/s00436-006-0405-7
pmid: 17177056
|
[18] |
张榕燕, 谢贤良, 方彦炎. 福建省58例广州管圆线虫病分析[J]. 海峡预防医学杂志, 2017, 23(1):27-29.
|
[19] |
Evans-Gilbert T, Lindo JF, Henry S, et al. Severe eosinophilic meningitis owing to Angiostrongylus cantonensis in young Jamaican children: case report and literature review[J]. Paediatr Int Child Health, 2014, 34(2):148-152.
|
[20] |
Jhan KY, Cheng CJ, Chou CJ, et al. Improvements of cognitive functions in mice heavily infected by Angiostrongylus cantonensis after treatment with albendazole, dexamethasone, or co-therapy[J]. J Microbiol Immunol Infect, 2022, 55(5):935-945.
|
[21] |
Jhan KY, Cheng CJ, Jung SM, et al. Co-therapy of albendazole and dexamethasone reduces pathological changes in the cerebral parenchyma of Th-1 and Th-2 dominant mice heavily infected with Angiostrongylus cantonensis: histopathological and RNA-seq analyses[J]. Biomolecules, 2021, 11(4):536.
|
[22] |
刘玉婷, 厉广栩. 儿童重型广州管圆线虫病1例[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(6):813-816.
doi: 10.12140/j.issn.1000-7423.2022.06.021
|
[23] |
Pham Thu H, Đao Huu N, Thi Thu TL, et al. Case report: Angiostrongylus cantonensis meningoencephalitis in a 9-month-old baby in Vietnam[J]. Am J Trop Med Hyg, 2020, 103(2):723-726.
|
[24] |
Liu J, Tao JH, Chen WM, et al. The application of metagenomic next-generation sequencing for Angiostrongylus eosinophilic meningitis in a pediatric patient: a case report[J]. Front Public Health, 2022, 10:1003013.
|
[25] |
Tu WC, Lai SC. Angiostrongylus cantonensis: efficacy of albendazole-dexamethasone co-therapy against infection-induced plasminogen activators and eosinophilic meningitis[J]. Exp Parasitol, 2006, 113(1):8-15.
|
[26] |
Jacob J, Steel A, Lin Z, et al. Clinical efficacy and safety of albendazole and other benzimidazole anthelmintics for rat lungworm disease (neuroangiostrongyliasis): a systematic analysis of clinical reports and animal studies[J]. Clin Infect Dis, 2022, 74(7):1293-1302.
|
[27] |
Chen KY, Cheng CJ, Chen YJ, et al. Protective effect of benzaldehyde combined with albendazole against brain injury induced by Angiostrongylus cantonensis infection in mice[J]. Int J Antimicrob Agents, 2023, 62(5):106963.
|
[28] |
Roquini DB, Silva GL, Ferreira LLG, et al. Susceptibility of Angiostrongylus cantonensis larvae to anthelmintic drugs[J]. Front Pharmacol, 2022, 13:901459.
|
[29] |
Jacob J, Tan G, Lange I, et al. In vitro efficacy of anthelmintics on Angiostrongylus cantonensis L3 larvae[J]. Parasitology, 2021, 148(2):240-250.
|